Are the percutaneous techniques well enough to approach the Secondary Mitral Valve Regurgitation? Getting to the heart of it. Nosce te ipsum

Ovidio A García-Villarreal

2020, Number 2

<< Back Next >>

Cir Card Mex 2020; 5 (2)

Are the percutaneous techniques well enough to approach the Secondary Mitral Valve Regurgitation? Getting to the heart of it. Nosce te ipsum

García-Villarreal OA

Full text

How to cite this article

Language: English
References: 20
Page: 38-41
PDF size: 209.39 Kb.

ABSTRACT

Mitral valve repair has dramatically evolved over the years every since its inception from the "French Correction" by Alain F. Carpentier. The Golden rule inside this one is always working on a frame by means of a prosthetic annuloplasty ring, regardless the specific chosen technique. MitraClip is an excellent tool when correctly indicated, especially in desperate cases out of surgical treatment because a prohibitive high-risk operative mortality. However, it is still very limited since it is a ringless therapy. There are two main peaks for failure after operation when ringless condition is present; namely, at 5 years and 12 years. It’s really astonishing how this of paramount significance fact has been ignored by cardiologists. This is why COAPT trial analysis at 2 years turned out to be favorable. Plain and simple!

REFERENCES

Carpentier A. Reconstructive valvuloplasty. A new technique of mitral valvuloplasty.Presse Med 1969;77(7):251-3.
Carpentier A, Deloche A, Dauptain J, Soyer R, Blondeau P, Piwnica A, Dubost C,McGoon DC. A new reconstructive operation for correction of mitral and tricuspidinsufficiency. J Thorac Cardiovasc Surg 1971;61(1):1-13.
Carpentier A. Cardiac valve surgery--the "French correction". J Thorac CardiovascSurg 1983;86(3):323-37.
Alfieri O. The genesis of the Edge-to-Edge technique. The first case. In: AlfieriO, et al (eds). Edge-to-Edge Mitral Repair: From Surgical to a Percutaneous approach.©Springer International Publishing Switzerland 2015.
Alfieri O. The genesis of the Edge-to-Edge technique. Initial experience, refinementsand validation. In: Alfieri O, et al (eds). Edge-to-Edge Mitral Repair: FromSurgical to a Percutaneous approach. ©Springer International Publishing Switzerland2015.
Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitralvalverepair: a simple solution for complex problems. J Thorac Cardiovasc Surg2001;122(4):674-81.
De Bonis M, Lapenna E, Maisano F, et al. Long tern results (≤ 18 years) of theedge-to-edge mitral valve repair without annuloplasty ring in degenerative mitralregurgitation. Circulation 2014;130 [Suppl 1]:S19-24.
De Bonis M, Lapenna E, Pozzoli A, Giacomini A, Alfieri O. Edge-to-edge surgicalmitral valve repair in the era of MitraClip. What if the annuloplasty is missed?Curr Opin Cardiol 2015;30:155-60.
García-Villarreal OA. Mitral annuloplasty in the era of “ringless” MitraClip: Allcats are grey in the dark. Cir Card Mex 2018; 2018; 3(4): 115-9.
Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitralregurgitation. N Engl J Med 2011;364: 1395-406.
Bolling SF, Deeb GM, Brunsting LA, Bach DS. Early outcome of mitral valvereconstruction in patients with end-stage cardiomyopathy. J Thorac CardiovascSurg 1995;109:676–82.
Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitralreconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998;115:381–6.
https://www.thecardiologyadvisor.com/home/decision-support-in-medicine/cardiology/secondary-functional-mitral-regurgitation/ Accesed Feb 11, 2020.
Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medicaltreatment for secondary mitral regurgitation. N Engl J Med 2018;379:2297–306.
Mack MJ, Abraham WT, Lindenfeld JA, et al. Cardiovascular Outcomes Assessmentof the MitraClip in Patients with Heart Failure and Secondary MitralRegurgitation: Design and Rationale of the COAPT Trial. Am Heart J (2018),doi:10.1016/ j.ahj.2018.07.021.
Stone GW, Lindenfeld JA, Abraham WT, et al. for the COAPT Investigators.Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med2018;379:2307-18.
Asch FM, Grayburn PA, Siegel RJ, et al. On behalf of the COAPT Investigators.Transcatheter Mitral Valve Replacement in Patients with Heart Failure and SecondaryMitral Regurgitation: From COAPT Trial. J Am Coll Cardiol (2019). doi:https://doi.org/10.1016/j.jacc.2019.09.017
Atianzar K, Zhang M, Newhart, Gafoor S. Why Did COAPT Win While MITRA-FR Failed? Defining the Appropriate Patient Population for MitraClip. InterventionalCardiology Review 2019;14(1):45–7.
Frerker C, Schmidt T, Pfister R, et al. Cardioband®: Where do we stand, whoare suitable patients? Herz 2019;44(7):596-601. doi: 10.1007/s00059-019-4839-y.[Article in German].
Weber M, Öztürk C, Taramasso M, et al. Leaflet edge-to-edge treatment versus directannuloplasty in patients with functional mitral regurgitation. EuroIntervention2019; 15(10):912-8. doi: 10.4244/EIJ-D-19-00468.